Topics

Companies Related to "Adaptimmune Therapeutics ADAP Adrian Rawcliffe 2019 Results Earnings" [Most Relevant Company Matches] RSS

10:25 EST 6th December 2019 | BioPortfolio

Here are the most relevant search results for "Adaptimmune Therapeutics ADAP Adrian Rawcliffe 2019 Results Earnings" found in our extensive corporate database of over 50,000 company records.

Showing "Adaptimmune Therapeutics ADAP Adrian Rawcliffe 2019 Results Earnings" Companies 1–25 of 3,100+

Relevant

Adrian Fisher Associates Limited

Adrian Fisher Associates is a specialised retained executive search consultancy operating throughout the UK and Internationally, specialising in serving the Healthcare, Scientific and Life Science marketplaces.


Adaptimmune Limited

Adaptimmune Limited is focused on the use of T cell therapy to treat HIV and cancer. It aims to utilize the body’s own machinery – the T lymphocyte cell – to target and destroy cancerous or infected cells.  Established in July 2008, Adaptimmune was set up to develop Immunocore Ltd’s (formerly Avidex/MediGeneLtd’s) unique T cell receptor engineering technology f...

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...


PRTM

PRTM has followed one principle since our founding in 1976—to make a lasting difference for our clients. The only way we can get those kinds of results is to work relentlessly and passionately as a global team with our clients.What does that mean? It means we offer insights with the power to transform the very way a company operates. We live and breathe your ecosystem, your business, your operat...

Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company’s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with ...

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located at Milton Park, near Oxford. The company traces its roots back to Avidex Limited which was founded in 1999 as a spin-out from the University of Oxford to develop technology invented by the founder and...

Capital Earnings & Research

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...

Maze Therapeutics

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas, coupled with deep biological insights and advanced data science tools, have enabled Maze to understand the ways modifier genes can confer protection. Maze will create therapi...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

Ballantyne Strong, Inc.

http://www.strong-world.com (Investor Relations section) or www.earnings.com

Oxford Outcomes

Oxford Outcomes is an international consultancy which specialises in patient-reported outcomes, health economics, epidemiology and health programme evaluation. The company has offices in Oxford and Vancouver, as well as a new office opened in Washington D.C. in June 2006. The consultancy team isled by Diane Wild, Andrew Briggs, Adrian Levy, Maggie Tabberer, Kathy Beusterien and Mark Sculpher, supp...

Affluent Medical

Results have been presented Saturday February 9th, 2019 at Controversies And Updates in Vascular Surgery congress (CACVS) in Paris by Professor Dominique Fabre, MD, principal investigator. Study contributors are Frederic Cochennec, MD, Claude Angel, MD, Eric Allaire, MD, Philippe Brenot, MD, Riyad Bourkaib MD, Jean-Yves Riou, MD, Pascal Desgranges, MD, Ben...

Avidity Biosciences, Inc.

Avidity Biosciences, Inc. is a privately-held biotech company pioneering Antibody-Oligonucleotide Conjugates (AOC™) for treatment of rare muscle disorders and other serious diseases. AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to enable more effective targeting of tissues, such as skeletal muscle, immune cells, and hear...

SpringWorks Therapeutics, Inc.

At SpringWorks Therapeutics, a clinical-stage biopharmaceutical company, we are driven to develop life-changing medicines for patients with severe rare diseases and cancer. Since our launch in 2017, we have worked to identify and advance promising science, beginning with our licensed clinical therapies from Pfizer Inc. We pioneer efficient pathways for dru...

ASPIRE 2019 Congress

Alcresta Therapeutics, Inc.

Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency, which results in malabsorption common in cysti...

Vitruvius Therapeutics Inc.

Vitruvias is a generic pharmaceutical company which utilizes domestic and international partnerships to develop, manufacture, and market technically difficult generic products. Founded in 2013, the company’s primarily focus is on products in the generic sterile injectable market, semi-solid market, and selected high-value oral solids The Company recei...

Noveome Biotherapeutics, Inc.

Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues. Noveome’s multi-target platform biologic and lead product, ST266, is a complex, non-cellular product containing hundreds of biologically acti...

Hinduja Global Solutions

A global leader in business process management (BPM) and optimizing the customer experience lifecycle, HGS is helping make its clients more competitive every day. HGS combines technology-powered services in automation, analytics and digital with domain expertise focusing on back office processing, contact centers and HRO solutions to deliver transformational impact to clients. Part of the multi-b...

RAPT Therapeutics, Inc.

RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company develops highly selective small molecu...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

Probably Relevant

FUJIFILM Irvine Scientific, Inc.

2. Date of change: January 1, 2019 in the United States

Pennsylvania Association of Staff Nurses and Allied Professionals (PASNAP)

For: June 27, 2019


More From BioPortfolio on "Adaptimmune Therapeutics ADAP Adrian Rawcliffe 2019 Results Earnings"

Quick Search

Corporate Database Quicklinks